Get the Stockscreener App
144.96
3.06%
4.31
After Hours:
144.96
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $144.96, with a volume of 983.81K.
It is up +3.06% in the last 24 hours and down -1.58% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$140.65
Open:
$140.1
24h Volume:
983.81K
Relative Volume:
1.38
Market Cap:
$7.87B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.72
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-2.05%
1M Performance:
-1.58%
6M Performance:
-12.90%
1Y Performance:
+0.51%
1-Day Range:
$140.10
$145.61
1-Week Range:
$138.68
$148.59
52-Week Range:
$133.70
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
144.96 | 7.64B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Smart tools for monitoring Masimo Corporation’s price action2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Why institutional investors increase stakes in Masimo Corporation (3M4) stockJuly 2025 Outlook & Free Technical Pattern Based Buy Signals - newser.com
Is Masimo Corporation stock a top momentum playWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Montanaro Asset Management Ltd Decreases Stake in Masimo Corporation $MASI - MarketBeat
Apple Watch Patent Trial to Turn on Storytelling, Not Sensors - Bloomberg Law News
Simon Quick Advisors LLC Acquires Shares of 2,267 Masimo Corporation $MASI - MarketBeat
Is Masimo Corporation (3M4) stock a buy before new product rolloutPortfolio Performance Summary & Stepwise Swing Trade Plans - newser.com
Earnings To Watch: Masimo (MASI) Reports Q3 Results Tomorrow - Yahoo! Finance Canada
Will Masimo Corporation stock recover after recent dropMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
What Fibonacci levels say about Masimo Corporation reboundJuly 2025 Reactions & Long-Term Growth Plans - newser.com
Strs Ohio Has $9.42 Million Stock Position in Masimo Corporation $MASI - MarketBeat
MASIMO Earnings Preview: Recent $MASI Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Real time pattern detection on Masimo Corporation stockExit Point & AI Driven Price Predictions - newser.com
Masimo Corporation (MASI) Stock Forecasts - Yahoo Finance
Masimo Corp expected to post earnings of $1.20 a shareEarnings Preview - TradingView
Masimo Corp. Explores New Frontiers in Sleep Therapy with PROSOMNIA Study - TipRanks
Is Masimo Corporation (3M4) stock dividend growth reliable2025 Price Targets & AI Enhanced Trading Signals - newser.com
Apple Spared From Some Masimo Patent Claims Before Trial - Law360
Masimo’s Study on Pulse Oximetry and Skin Pigmentation: A Potential Game-Changer - The Globe and Mail
Apple, Masimo Fight Over Experts as Apple Watch Trial Looms - Bloomberg Law News
What Masimo (MASI)'s Study on SpO2 Accuracy Across Skin Tones Means for Shareholders - simplywall.st
Masimo Corporation $MASI Stake Lessened by Logan Capital Management Inc. - MarketBeat
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why Masimo Corporation stock attracts high net worth investors2025 Technical Patterns & Fast Exit and Entry Strategy Plans - fcp.pa.gov.br
This Week in Chancery Court: Tesla’s Lawyer Fees Appeal, Masimo - Bloomberg Law News
Sumitomo Mitsui Trust Group Inc. Has $79.24 Million Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo (NASDAQ:MASI) Earns "Sell (D)" Rating from Weiss Ratings - MarketBeat
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions - Yahoo Finance
Nordea Investment Management AB Buys 5,659 Shares of Masimo Corporation $MASI - MarketBeat
Masimo (NASDAQ: MASI) sets Nov 4 results call hosted by CEO Katie Szyman, CFO Micah Young - Stock Titan
Masimo Corporation $MASI Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Why Masimo Corporation stock appeals to dividend seekersWeekly Trade Review & Free High Accuracy Swing Entry Alerts - newser.com
Here's Why Masimo (MASI) is a Strong Growth Stock - Yahoo Finance
Has Masimo Corporation formed a bullish divergence2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
Why Masimo Corporation (3M4) stock remains stableJuly 2025 Breakouts & Verified Momentum Watchlists - nchmf.gov.vn
Combining machine learning predictions for Masimo Corporation2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
How Masimo Corporation (3M4) stock compares with tech leadersWeekly Profit Analysis & Safe Entry Trade Signal Reports - Trung tâm Dự báo KTTV quốc gia
RFG Advisory LLC Trims Position in Masimo Corporation $MASI - MarketBeat
Masimo (MIL:1MASI) Accounts Payable : €118 Mil (As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) Operating Cash Flow per Share : €2.95 (TTM As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) 5-Year ROIIC % : -10.39% (As of Dec. 2024) - GuruFocus
Masimo (MIL:1MASI) Net Debt Paydown Yield % : 0% (As of Oct. 17, 2025) - GuruFocus
Masimo (MIL:1MASI) Cash Flow from Financing : €-86 Mil (TTM As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) Goodwill-to-Asset : 0.04 (As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) FCF Yield % : 1.68 (As of Oct. 17, 2025) - GuruFocus
Masimo (MIL:1MASI) Asset Turnover : 0.15 (As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) ROC % : 10.31% (As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) Book Value per Share : €16.64 (As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) EBIT : €-189 Mil (TTM As of Jun. 2025) - GuruFocus
Masimo (MIL:1MASI) OCF Yield % : 2.19 (As of Oct. 17, 2025) - GuruFocus
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):